Kim Forest Enterprise Co Ltd banner

Kim Forest Enterprise Co Ltd
TWSE:6645

Watchlist Manager
Kim Forest Enterprise Co Ltd Logo
Kim Forest Enterprise Co Ltd
TWSE:6645
Watchlist
Price: 13.65 TWD -1.09% Market Closed
Market Cap: NT$830.7m

Kim Forest Enterprise Co Ltd
Investor Relations

Kim Forest Enterprise Co., Ltd. engages in sale of instruments and reagents needed for new drug research and development. The company is headquartered in Taipei, New Taipei. The company went IPO on 2017-08-18. The firm operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.

Show more
Loading
6645
Taiwan Weighted Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Daniel Huang
Chief Executive officer
No Bio Available

Contacts

Address
NEW TAIPEI
Taipei
30F, No.97, Section 1, Xintai 5th Road, Xizhi District
Contacts
+886226976888
www.kimforest.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett